His primary areas of study are Biochemistry, Receptor, Nuclear receptor, Internal medicine and Endocrinology. The study of Biochemistry is intertwined with the study of Glucose homeostasis in a number of ways. As part of the same scientific family, Patrick R. Griffin usually focuses on Receptor, concentrating on RAR-related orphan receptor alpha and intersecting with Retinoic acid and Coactivator.
His Nuclear receptor research includes themes of Peroxisome proliferator-activated receptor, RAR-related orphan receptor gamma, HEK 293 cells, Cell biology and Binding site. His Peroxisome proliferator-activated receptor research is multidisciplinary, incorporating perspectives in Rosiglitazone, Stereochemistry and Phosphorylation. His research in Enzyme intersects with topics in Oxidative phosphorylation and Nitric oxide.
Biochemistry, Receptor, Cell biology, Nuclear receptor and Biophysics are his primary areas of study. In most of his Biochemistry studies, his work intersects topics such as Molecular biology. His study in Receptor is interdisciplinary in nature, drawing from both Ligand, Pharmacology and Small molecule.
His research is interdisciplinary, bridging the disciplines of Allosteric regulation and Cell biology. His work in Nuclear receptor covers topics such as Peroxisome proliferator-activated receptor which are related to areas like Endocrinology. His study looks at the relationship between Biophysics and topics such as Hydrogen–deuterium exchange, which overlap with Stereochemistry.
His primary scientific interests are in Cell biology, Receptor, Nuclear receptor, Biophysics and Hydrogen–deuterium exchange. His work deals with themes such as RNA, Helicase, Cell and Small molecule, which intersect with Cell biology. He combines subjects such as Ligand, Pharmacology and Function with his study of Receptor.
His Nuclear receptor study combines topics from a wide range of disciplines, such as Coactivator, Agonist, Inverse agonist, Nuclear magnetic resonance spectroscopy and In vivo. As a part of the same scientific family, Patrick R. Griffin mostly works in the field of Inverse agonist, focusing on Peroxisome proliferator-activated receptor and, on occasion, Corepressor. His research integrates issues of Protein structure, Gap junction, Allosteric regulation and Binding site in his study of Biophysics.
His main research concerns Cell biology, Receptor, Biophysics, Nuclear receptor and Protein structure. Patrick R. Griffin works in the field of Cell biology, focusing on Signal transduction in particular. His Receptor study integrates concerns from other disciplines, such as Cell, Retinoic acid and Pharmacology.
His Biophysics research is multidisciplinary, incorporating elements of Coactivator, Peroxisome proliferator-activated receptor, Allosteric regulation and Corepressor. His Nuclear receptor research incorporates elements of Nuclear magnetic resonance spectroscopy, Binding site and Mass spectrometry. His Protein structure research incorporates themes from Cytoplasm, Hydrogen–deuterium exchange, Cryo-electron microscopy, Steric effects and Inverse agonist.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
Nicholson Dw;Ali A;Thornberry Na;Vaillancourt Jp.
Nature (1995)
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
Andrew D. Howard;Scott D. Feighner;Doris F. Cully;Joseph P. Arena.
Science (1996)
Peptide mass maps: a highly informative approach to protein identification.
J.R. Yates;S. Speicher;P.R. Griffin;T. Hunkapiller.
Analytical Biochemistry (1993)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi;Alexander S. Banks;Jennifer L. Estall;Shingo Kajimura.
Nature (2010)
Peroxynitrite reductase activity of bacterial peroxiredoxins
Ruslana Bryk;Patrick Griffin;Carl Nathan.
Nature (2000)
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.
Bei Zhang;Gino Salituro;Deborah Szalkowski;Zhihua Li.
Science (1999)
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Yanyong Kang;X. Edward Zhou;Xiang Gao;Yuanzheng He.
Nature (2015)
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Jang Hyun Choi;Alexander S. Banks;Theodore M. Kamenecka;Scott A. Busby.
Nature (2011)
Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand
Laura A. Solt;P. Naresh Kumar;Philippe Nuhant;Yongjun Wang.
Nature (2011)
Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones.
Nancy A. Thornberry;Erin P. Peterson;Justin J. Zhao;Andrew D. Howard.
Biochemistry (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Scripps Research Institute
Washington University in St. Louis
University of Virginia
Chinese Academy of Sciences
Harvard University
Van Andel Institute
University of Illinois at Urbana-Champaign
National Institute of Diabetes and Digestive and Kidney Diseases
University of Southern California
University of Illinois at Urbana-Champaign
National University of Singapore
University of North Carolina at Charlotte
Northwestern University
University of Utah
Shanghai Jiao Tong University
Indian Institute of Technology Kanpur
University of Oslo
University of Toronto
University of Western Australia
University of Kentucky
University of Strasbourg
The Ohio State University Wexner Medical Center
Imperial College London
Kiel University
Radboud University Nijmegen
National Institute for Astrophysics